Diabetes

Glucagon receptor antagonist ups blood pressure in T2DM

(HealthDay)—For patients with type 2 diabetes, once-daily treatment with the glucagon receptor antagonist LY2409021 is associated with increases in ambulatory blood pressure (BP), according to a study published online Feb. ...

HIV & AIDS

Progress toward HIV cure highlighted

A comprehensive collection of articles describing the broad scope and current status of this global effort is published in a special issue of AIDS Research and Human Retroviruses.

Surgery

Good long-term results of obesity surgery in young people

Bariatric surgery on teenagers gives results that are equally as good as for adults, but the operations carries complications. Five years after surgery, the patients weighed on average 28 per cent less than beforehand, a ...

Diseases, Conditions, Syndromes

Silencing fat protein improves obesity and blood sugar

In a study published in the Journal of Lipid Research, Saint Louis University scientist Angel Baldan, Ph.D., reports that turning off a protein found in liver and adipose tissue significantly improves blood sugar levels, ...

Health

Modern hunter-gatherers show value of exercise

In a remote area of north-central Tanzania, men leave their huts on foot, armed with bows and poison-tipped arrows, to hunt for their next meal. Dinner could come in the form of a small bird, a towering giraffe or something ...

Diabetes

Review compares outcomes, safety for once-weekly GLP-1RAs

(HealthDay)—Cardiometabolic outcomes and safety vary among different once-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) treatments, according to a review published online Dec. 8 in the Annals of Internal Medicine.

page 4 from 9